Clinical Trials Directory

Trials / Conditions / Adult Anaplastic Ependymoma

Adult Anaplastic Ependymoma

15 registered clinical trials studyying Adult Anaplastic Ependymoma.

StatusTrialSponsorPhase
CompletedAlisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
NCT02186509
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 1
Terminated18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
NCT02175745
Erik MittraN/A
WithdrawnEfficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
NCT02194452
Sue O'DorisioN/A
Terminated3T MRI Biomarkers of Glioma Treatment Response
NCT01996527
Vanderbilt-Ingram Cancer CenterEARLY_Phase 1
TerminatedGadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients Wi
NCT02967380
University of Southern CaliforniaN/A
TerminatedEfficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
NCT01478321
Northwestern UniversityPhase 2
TerminatedYoga Therapy in Treating Patients With Malignant Brain Tumors
NCT01234805
Wake Forest University Health SciencesN/A
CompletedBafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
NCT01234740
City of Hope Medical CenterPhase 1
CompletedFluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With
NCT01165632
Mayo ClinicEARLY_Phase 1
CompletedGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
NCT01131234
National Cancer Institute (NCI)Phase 1
CompletedRO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
NCT01119599
National Cancer Institute (NCI)Phase 1
CompletedBevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Pri
NCT00492089
National Cancer Institute (NCI)Phase 2
TerminatedPositron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergo
NCT00110032
National Cancer Institute (NCI)Phase 1
CompletedErlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
NCT00030498
National Cancer Institute (NCI)Phase 1
TerminatedUse of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagn
NCT00430079
National Cancer Institute (NCI)N/A